scispace - formally typeset
M

Mohamed H. Ramadan

Researcher at Carnegie Mellon University

Publications -  6
Citations -  1377

Mohamed H. Ramadan is an academic researcher from Carnegie Mellon University. The author has contributed to research in topics: Analyte & Self-healing hydrogels. The author has an hindex of 5, co-authored 6 publications receiving 989 citations.

Papers
More filters
Journal ArticleDOI

Three-dimensional printing of complex biological structures by freeform reversible embedding of suspended hydrogels.

TL;DR: Three-dimensional structures based on femurs, branched coronary arteries, trabeculated embryonic hearts, and human brains were mechanically robust and recreated complex 3D internal and external anatomical architectures.
Journal ArticleDOI

Therapeutic intradermal delivery of tumor necrosis factor-alpha antibodies using tip-loaded dissolvable microneedle arrays.

TL;DR: Efficient and biologically effective MNA delivery of anti-TNF-α Ab to the intradermal microenvironment of the skin in mice and humans is demonstrated and these results support the development of MNA mediated antibody delivery of therapeutic antibodies for clinical applications.
Journal ArticleDOI

Reducing protein adsorption with polymer-grafted hyaluronic acid coatings

TL;DR: It is concluded that PMEO2MA-grafted HA is a versatile platform for the passivation of hydrophobic biomaterial surfaces without need for substrate functionalization.
Journal ArticleDOI

Tip-Loaded Dissolvable Microneedle Arrays Effectively Deliver Polymer-Conjugated Antibody Inhibitors of Tumor-Necrosis-Factor-Alpha Into Human Skin.

TL;DR: Results indicate TL-dMNAs can be successfully fabricated to integrate (anti-TNF-α-Ab)-HA at the tip portion of the microneedles while preserving the biological activity necessary for antibody ligand binding, and polymer conjugation effectively inhibits antibody diffusion from the delivery site.
Journal ArticleDOI

Polymer-conjugated inhibitors of tumor necrosis factor-α for local control of inflammation

TL;DR: Fundamental aspects of medical conditions that could be treated with cytokine-neutralizing polymer conjugates are discussed and design principles for preparing these cytokines neutralize to high molecular weight hydrophilic polymers are discussed.